Publications
5491 Results
- Journal / Conference
- Society for Immunotherapy of Cancer (SITC) (Nov 8-12,2022, Boston, MA), poster
- Year
- 2022
- Research Committee(s)
- Lung
- Study Number(s)
- S1400A, S1400I
Lung-MAP Composite Signature for Immune Checkpoint Inhibitor (ICI) Efficacy in Advanced Squamous Cell Lung Cancer (SCC)
- Journal / Conference
- ASCO Quality Care Symposium (September 30 - October 1, 2022, Chicago, IL), poster
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1415CD
Can order entry systems improve oncology practice? The TrACER Experience
- Journal / Conference
- ASCO Quality Care Symposium (September 30 - October 1, 2022, Chicago, IL), poster
- Year
- 2022
- Research Committee(s)
- Symptom Control and Quality of Life
- Study Number(s)
- S0927, S1200, S1202
Socioeconomic Deprivation and Patient-Reported Outcomes in Symptom Management Trials for Breast Cancer Patients
- Journal / Conference
- ASCO Quality Care Symposium (September 30 - October 1, 2022, Chicago, IL), poster
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
Survival Outcomes by Insurance Status for Cancer Patients Treated in Clinical Trials
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), poster #P2-11-11
- Year
- 2022
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814
Computer analysis of nuclear morphology with Multiple Instance Learning Predicts Overall Survival for LN+ Breast Cancer Patients from SWOG S8814: A Blinded Validation Study
- Journal / Conference
- International Symposium on Hodgkin Lymphoma (October 22-24, 2022, Cologne, Germany), poster
- Year
- 2022
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816
ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA (CHL) PATIENTS WITH A POSITIVE INTERIM-PET DEAUVILLE SCORE 5 AFTER 2 ABVD CYCLES: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA OF THREE MULTICENTER TRIALS
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), oral
- Year
- 2022
- Research Committee(s)
- Breast
- Study Number(s)
- S1207
Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- everolimus in patients with high-risk, hormone receptor (HR) positive, HER2-negative breast cancer (BC): SWOG/NRG/Alliance S1207 (NCT01674140)
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), poster
- Year
- 2022
- Research Committee(s)
- Breast
- Study Number(s)
- S1007
Patient-reported anxiety and fatigue in women enrolled in the RxPONDER trial (SWOG S1007) by menopausal status
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), oral
- Year
- 2022
- Research Committee(s)
- Breast
- Study Number(s)
- S1007
Patient-reported cognitive impairment in women participating in the RxPONDER trial (SWOG S1007) by menopausal status
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), PD6-04, Spotlight Poster Discussion presentation
- Year
- 2022
- Research Committee(s)
- Multiple sites